Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NPWT patient outreach

This article was originally published in The Gray Sheet

Executive Summary

Smith & Nephew is launching a negative pressure wound therapy hotline for patients. Announced June 7, the hotline (1-866-998-NPWT) was previously only available to clinicians, but now patients can speak to dedicated support staff about the company's Renasys NPWT products. "The clinical hotline is a component of our investment in a comprehensive program to support the patient receiving NPWT in the home and further support appropriate product utilization and patient education," said Patricia Burns, senior director of clinical affairs. Smith & Nephew recently lost a patent infringement suit brought by V.A.C maker Kinetic Concepts relating to its Renasys-F foam dressing kit, but the firm is appealing the verdict (1"The Gray Sheet" March 15, 2010)

You may also be interested in...



KCI Wins Negative Pressure Wound Therapy Patent Suit Over Smith & Nephew

V.A.C. maker Kinetic Concepts claimed victory over Smith & Nephew in a long-standing negative pressure wound therapy patent infringement suit, but Smith & Nephew plans to appeal the verdict

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029008

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel